Regulation of profibrotic SPP1-expressing macrophages by tfeb in SSC

Ended Project Grant Awarded Last action

Award ID
W81XWH2210512
Recipient
Awarding agency
Obligated
$494,458

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Place of performance
Pittsburgh, PA 15260, USA

Award details come from USAspending.gov.

About this award

The University of Pittsburgh was awarded a $494,458 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The three-year grant will fund research to regulate profibrotic SPP1-expressing macrophages by TFEB in SSc. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military and public health care through innovative medical solutions for battlefield injuries. This award will advance those goals by investigating potential treatments for systemic sclerosis, a rare autoimmune disease causing thickening and scarring of the skin and internal organs. Research will be conducted in Pittsburgh, Pennsylvania from July 1, 2022 through June 30, 2025.

Quick answers

Who received award W81XWH2210512?

W81XWH2210512 was awarded to University Of Pittsburgh - Of The Commonwealth System Of Higher Education by Medical Command (Department of the Army) on July 1, 2022.

How much is award W81XWH2210512 worth?

$494,458 has been obligated on W81XWH2210512.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award